atomoxetine stada hart hylki 80 mg
stada arzneimittel ag - atomoxetinum hýdróklóríð - hart hylki - 80 mg
bloxazoc forðatafla 200 mg
krka d.d. novo mesto - metoprololum súkkínat - forðatafla - 200 mg
bloxazoc forðatafla 50 mg
krka d.d. novo mesto - metoprololum súkkínat - forðatafla - 50 mg
metoprolol alvogen (metoprolol ratiopharm) forðatafla 23,75 mg
alvogen ehf. - metoprololum súkkínat - forðatafla - 23,75 mg
metoprolol alvogen (metoprolol ratiopharm) forðatafla 47,5 mg
alvogen ehf. - metoprololum súkkínat - forðatafla - 47,5 mg
dutaprostam hart hylki 0,5/0,4 mg
zentiva k.s.* - dutasteridum inn; tamsulosinum hýdróklóríð - hart hylki - 0,5/0,4 mg
fluconazol krka hart hylki 150 mg
krka sverige ab - fluconazolum inn - hart hylki - 150 mg
fluconazol krka hart hylki 200 mg
krka sverige ab - fluconazolum inn - hart hylki - 200 mg
fluconazol krka hart hylki 50 mg
krka sverige ab - fluconazolum inn - hart hylki - 50 mg
sivextro
merck sharp & dohme b.v. - tedizólíð fosfat - soft tissue infections; skin diseases, bacterial - antibacterials for systemic use, , other antibacterials - sivextro is indicated for the treatment of acute bacterial skin and skin structure infections (absssi) in adults and adolescents 12 years of age and older.